MPM BIOVENTURES III GP LP

10% owner at TERCICA INC · on record since Mar 16, 2004
10% owner at HELICOS BIOSCIENCES CORP · on record since May 31, 2007
10% owner at PONIARD PHARMACEUTICALS, INC. · on record since Apr 27, 2006
10% owner at AFFYMAX INC · on record since Dec 21, 2006
10% owner at COTHERIX INC · on record since Jan 10, 2007
10% owner at Pharmasset Inc · on record since Apr 26, 2007
10% owner at Pernix Sleep, Inc. · on record since May 10, 2007
See explanation below at Altimmune, Inc. · on record since Aug 7, 2007
10% owner at Altimmune, Inc. · on record since Aug 7, 2007
10% owner at BARRIER THERAPEUTICS INC · on record since Apr 28, 2004
10% owner at ReShape Weightloss Inc. · on record since Nov 21, 2007
10% owner at ARYx Therapeutics, Inc. · on record since Nov 13, 2007
10% owner at PEPLIN INC · on record since Oct 30, 2008
10% owner at RIGEL PHARMACEUTICALS INC · on record since Jul 8, 2003
10% owner at EPIRUS Biopharmaceuticals, Inc. · on record since Dec 22, 2009
10% owner at CORNERSTONE THERAPEUTICS INC · on record since May 25, 2004
Former 10% Owner at ReShape Weightloss Inc. · on record since Dec 15, 2010
10% owner at METABASIS THERAPEUTICS INC · on record since Jun 15, 2004
10% owner at · on record since May 19, 2011
10% owner at · on record since Aug 10, 2012
Former 10% Owner at · on record since Sep 15, 2004
Former 10% stockholder at · on record since Sep 29, 2016
See Remarks at · on record since Mar 3, 2005

Insider trading activity of MPM BIOVENTURES III GP LP

Transactions on record: 21; since Jan 20, 2009

Open-market buys: 4; $80.4K

Open-market sells: 8; $14M

Companies traded: 6; last filing Feb 7, 2013

Figures computed from official regulatory filings — .

Companies where MPM BIOVENTURES III GP LP has traded

6 tx · Feb 7, 2013
2 tx · $11K · Jun 7, 2012
6 tx · $14M · Oct 25, 2011
2 tx · $1.3M · Oct 4, 2010
1 tx · $5K · Aug 17, 2010
4 tx · $80.4K · Jan 20, 2009

Track record of MPM BIOVENTURES III GP LP

Statistical track record

Free account

Open-market buys: 7

Last buy: Sep 30, 2010

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of MPM BIOVENTURES III GP LP

Co-insiders of MPM BIOVENTURES III GP LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
HUMANIGEN, INCListing unverified	Feb 7, 2013	Other	1,949,879	—	n/a (No price was disclosed in the filing)		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	Other	369,522	—	n/a (No price was disclosed in the filing)		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	Other	313,527	—	n/a (No price was disclosed in the filing)		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	OtherD (derivative)	-275,539	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	OtherD (derivative)	-337,622	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	OtherD (derivative)	-1,949,879	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Pernix Sleep, Inc.Listing unverified	Jun 7, 2012	Sell	-29,555	0.29 USD	$8.6K		SEC
Pernix Sleep, Inc.Listing unverified	Jun 7, 2012	Sell	-8,400	0.29 USD	$2.4K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 25, 2011	Sell	-70,100	1.02 USD	$71.5K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 25, 2011	Sell	-252,000	1.03 USD	$259.6K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 17, 2011	Sell	-39,700	1.02 USD	$40.5K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 17, 2011	Sell	-5,000	1.02 USD	$5.1K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 13, 2011	Sell	-131,800	102.00 USD	$13.4M		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 13, 2011	Sell	-206,500	1.02 USD	$210.6K		SEC
ReShape Weightloss Inc.Listing unverified	Oct 4, 2010	BuyD (derivative)	704,607	0.13 USD	$91.6K	ClusterUnusual size	SEC
ReShape Weightloss Inc.Listing unverified	Oct 4, 2010	BuyD (derivative)	704,607	1.72 USD	$1.2M	ClusterUnusual size	SEC
ARYx Therapeutics, Inc.Security delisted	Aug 17, 2010	BuyD (derivative)	500,000	0.01	$5K	ClusterFirst in 12mo	SEC
PEPLIN INCListing unverified	Jan 20, 2009	Buy	45	8.40	$378	conv 24Cluster	SEC
PEPLIN INCListing unverified	Jan 20, 2009	Buy	899	8.20	$7.4K	conv 33Cluster	SEC
PEPLIN INCListing unverified	Jan 20, 2009	Buy	7,340	8.20	$60.2K	conv 33Cluster	SEC
PEPLIN INCListing unverified	Jan 20, 2009	Buy	1,598	7.80	$12.5K	conv 41ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
HUMANIGEN, INCListing unverified	Feb 7, 2013	Other	1,949,879	—	n/a (No price was disclosed in the filing)		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	Other	369,522	—	n/a (No price was disclosed in the filing)		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	Other	313,527	—	n/a (No price was disclosed in the filing)		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	OtherD (derivative)	-275,539	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	OtherD (derivative)	-337,622	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Feb 7, 2013	OtherD (derivative)	-1,949,879	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Pernix Sleep, Inc.Listing unverified	Jun 7, 2012	Sell	-29,555	0.29 USD	$8.6K		SEC
Pernix Sleep, Inc.Listing unverified	Jun 7, 2012	Sell	-8,400	0.29 USD	$2.4K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 25, 2011	Sell	-70,100	1.02 USD	$71.5K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 25, 2011	Sell	-252,000	1.03 USD	$259.6K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 17, 2011	Sell	-39,700	1.02 USD	$40.5K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 17, 2011	Sell	-5,000	1.02 USD	$5.1K		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 13, 2011	Sell	-131,800	102.00 USD	$13.4M		SEC
EPIRUS Biopharmaceuticals, Inc.Listing unverified	Oct 13, 2011	Sell	-206,500	1.02 USD	$210.6K		SEC
ReShape Weightloss Inc.Listing unverified	Oct 4, 2010	BuyD (derivative)	704,607	0.13 USD	$91.6K	ClusterUnusual size	SEC
ReShape Weightloss Inc.Listing unverified	Oct 4, 2010	BuyD (derivative)	704,607	1.72 USD	$1.2M	ClusterUnusual size	SEC
ARYx Therapeutics, Inc.Security delisted	Aug 17, 2010	BuyD (derivative)	500,000	0.01	$5K	ClusterFirst in 12mo	SEC
PEPLIN INCListing unverified	Jan 20, 2009	Buy	45	8.40	$378	conv 24Cluster	SEC
PEPLIN INCListing unverified	Jan 20, 2009	Buy	899	8.20	$7.4K	conv 33Cluster	SEC
PEPLIN INCListing unverified	Jan 20, 2009	Buy	7,340	8.20	$60.2K	conv 33Cluster	SEC
PEPLIN INCListing unverified	Jan 20, 2009	Buy	1,598	7.80	$12.5K	conv 41ClusterFirst in 12mo	SEC